Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Spain – your gateway to Latin America? – part 2

Following my previous post on Spain I received the following email from Bernardo Mariano at ERDesk which I reproduce here with his permission:

I saw your article on Spain “Spain – your gateway to Latin America? – 8 October 2010” where you commented “Spain is a unique outlier in the global fragmentation ‘experiment’. Despite being part of Europe and subject to the MiFID best execution requirements introduced in November 2007, alternative venues have found it almost impossible to establish a foothold there.”
Spain has been immune to fragmentation given Iberclear’s settlement requirements – ie, to transfer ownership of stocks, Iberclear, needs an id number, which can only be generated from a trade on the exchange’s paltform (SIBE).

Chi-X and Turquoise tried to circumvent this requirement by aggregating trades and sending them to a local broker, which then execute them in the SIBE’s closing auction, but participants have been reluctant to change the existing settlement process(1)

BME’s position is very vulnerable to competition – 62% of its revenues come from equity trading and equity clearing & settlement . . .

Its fees are over 10x higher than ChiX’s

And 72% of its turnover is concentrated in five stocks traded across Europe

Bernardo Mariano

Leave a comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.